Browse > Article

Risk Factors for Local Tumor Recurrence after Segmental Transarterial Chemoembolization for Hepatocellular Carcinoma: the Importance of Tumor Located in the Segmental Border Zone  

Cho, Yun-Ku (Department of Radiology, Seoul Veterans Hospital)
Chung, Jin-Wook (Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine)
Ahn, Yong-Sik (Department of Radiology, Seoul Veterans Hospital)
Park, Yoon-Ok (Department of Radiology, Seoul Veterans Hospital)
Kim, Jae-Kyun (Department of Radiology, Seoul Veterans Hospital)
Byun, Jong-Hoon (Department of Internal Medicine, Seoul Veterans Hospital)
Publication Information
Korean Journal of Radiology / v.7, no.4, 2006 , pp. 267-274 More about this Journal
Abstract
Objective: We wanted to evaluate whether tumors located in a segmental border zone are predisposed to local recurrence after performing segmental transarterial chemoembolization for hepatocellular carcinoma. Materials and Methods: Seventy-three hepatocellular carcinoma nodules were retrospectively analyzed for local tumor recurrence after performing segmental transarterial chemoembolization by using follow-up CT studies (median follow-up period: 20 months, range: 4-77 months). The tumors were divided into two groups according to whether the lesions were located at the segmental border zone (Group I) or not (Group II). Comparison of the tumor characteristics and chemoembolization methods between the two groups was performed using the chi-square test. The local recurrence rates were compared by Kaplan-Meyer method and analyzed with the log rank test. Results: Local tumor recurrence occurred for 25 hepatocellular carcinoma nodules (42.9%). The follow-up periods, tumor characteristics and chemoembolization methods between Groups I and II were comparable. The local recurrence rate was 64.0% (16/25) in Group I and 18.8% (9/48) in Group II. The difference was statistically significant on the univariate and multivariate analyses (p=0.000 for both). Conclusion: Tumor location in a segmental border zone was a significant risk factor for local tumor recurrence after performing segmental transarterial chemoembolization for hepatocellular carcinoma.
Keywords
Liver neoplams, therapy; chemoembolization;
Citations & Related Records

Times Cited By Web Of Science : 5  (Related Records In Web of Science)
Times Cited By SCOPUS : 3
연도 인용수 순위
1 Nguyen M, Garcia R, Simpson P, Wright T, Keeffe E. Racial differences in effectiveness of alpha-fetoprotein for the diagnosis of hepatocellular carcinoma in hepatitis C cirrhosis. Hepatology 2002;36:410-417   DOI   ScienceOn
2 Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oil chemoembolization of hepatocellular carcinoma. Radiology 1989;170:783-786   DOI
3 Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 2001;176:681-688   DOI   ScienceOn
4 Choi SH, Chung JW, Lee HS. Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization. AJR Am J Roentgenol 2003;181:889-890   DOI
5 Maeda S, Fujiyama S, Tanaka M, Ashihara H, Hirata R, Tomita K. Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization. Hepatol Res 2002;23:202-210   DOI   ScienceOn
6 Pelletier G, Rohe A, Ink O, Anciaux ML, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11:181-184   DOI
7 Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, et al. Transcatheter oil chemoembolization for hepatocellular carcinoma: A 4-year study of 127 French patients. Cancer 1994;74:16-24   DOI   ScienceOn
8 Fischer L, Cardenas C, Thorn M, Benner A, Grenacher L, Lehnert T, et al. Limits of Couinaud's liver segment classification: a quantitative computer-based three-dimensional analysis. J Comput Assist Tomogr 2002;26:962-967   DOI   ScienceOn
9 Colella G, Bottelli R, De Carlis L, Sansalone CV, Rondinara GF, Alberti A, et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998;11:S193-S196   DOI
10 Choi D, Choo SW, Lim JH, Lee SJ, Do YS, Choo IW. Opacification of the intrahepatic portal veins during CT hepatic arteriography. J Comput Assist Tomogr 2001;25:218-224   DOI   ScienceOn
11 Segawa T, Izawa K, Tsunoda T, Kanematsu T, Shima M, Matsunaga N, et al. Evaluation of hepatectomy in small hepatocellular carcinoma: comparison with transcatheter arterial embolization therapy. Nippon Geka Gakkai Zasshi 1992;93:1095-1099
12 Takayasu K, Suzuki M, Uesaka K, Muramatsu Y, Moriyama N, Yoshida T, et al. Hepatic arterial embolization for inoperable hepatocellular carcinoma: prognosis and risk factors. Cancer Chemother Pharmacol 1989;23:S123-S125   DOI
13 Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Interv Radiol 1990;13:140-145   DOI
14 Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatoellular carcinoma. Cardiovasc Interv Radiol 1990;13:135-139   DOI